Man-Mei Long
Overview
Explore the profile of Man-Mei Long including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Long M, Dai S, Wang Z
Clin Exp Dermatol
. 2023 Jan;
48(4):394-395.
PMID: 36631893
No abstract available.
2.
Wei Z, Gu M, Chen Y, Liu C, Zhou H, Long M, et al.
Zhonghua Nan Ke Xue
. 2021 Dec;
27(9):787-792.
PMID: 34914253
Objective: To evaluate the safety and clinical efficiency of holmium laser enucleation of the prostate (HoLEP) in the treatment of small-volume BPH (SBPH) complicated by severe lower urinary tract symptoms...
3.
Wang W, Long M, Wei C, Cui X, Ren J, Gu Y, et al.
Ann Transl Med
. 2021 Aug;
9(13):1059.
PMID: 34422971
Background: Tenosynovial giant cell tumors (TGCTs), synovial chondromatosis (SC), and synovial sarcoma (SS) exhibit similarities in clinical features and histochemical characteristics, and differential diagnosis remains challenging in clinical practice. Methods:...
4.
Gu Y, Cui X, Ren J, Long M, Wang W, Wei C, et al.
PLoS One
. 2021 Feb;
16(2):e0241821.
PMID: 33630851
Real-time quantitative PCR (RT-qPCR) has been widely applied in uncovering disease mechanisms and screening potential biomarkers. Internal reference gene selection determines the accuracy and reproducibility of data analyses. The aim...
5.
Ren J, Gu Y, Cui X, Long M, Wang W, Wei C, et al.
Front Cell Dev Biol
. 2020 Nov;
8:582220.
PMID: 33163494
Malignant peripheral nerve sheath tumors (MPNST) are aggressive sarcomas with over half of cases developed in the context of neurofibromatosis type 1. Surgical resection is the only effective therapy for...
6.
Zhan M, Yang R, Wang H, He M, Chen W, Xu S, et al.
Cancer Commun (Lond)
. 2018 Jul;
38(1):48.
PMID: 30016995
Background: Gallbladder carcinoma is highly aggressive and resistant to chemotherapy, with no consistent strategy to guide first line chemotherapy. However, patient-derived xenograft (PDX) model has been increasingly used as an...
7.
Yang R, Zhan M, Xu S, Long M, Yang L, Chen W, et al.
Cell Death Dis
. 2017 Oct;
8(10):e3129.
PMID: 29048402
The highly refractory nature of pancreatic cancer (PC) to chemotherapeutic drugs is one of the key reasons contributing to the poor prognosis of this disease. MicroRNAs (miRNAs) are key regulators...
8.
Wang H, Zhan M, Xu S, Chen W, Long M, Shi Y, et al.
Cell Death Dis
. 2017 May;
8(5):e2770.
PMID: 28492560
Gallbladder cancer (GBC) is one of the most common malignancy of the biliary tract characterized by its high chemoresistant tendency. Although great progresses have been made in recent decades for...